Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Hai-Shan Ye"'
1
Akademický článek
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
Autor: Jun-Hua Nie, Tao Yang, Hong Li, Hai-Shan Ye, Guo-Qing Zhong, Ting-Ting Li, Chi Zhang, Wen-Han Huang, Jin Xiao, Zhi Li, Jian-Li He, Bo-Le Du, Yu Zhang, Jia Liu
Publikováno v: Journal of Bone Oncology, Vol 30, Iss , Pp 100391- (2021)
Background: Drug resistance and the lack of molecular therapeutic target are the main challenges in the management of osteosarcomas (OSs). Identification of novel genetic alteration(s) related with OS recurrence and chemotherapeutic resistance would
Externí odkaz: https://doaj.org/article/0efd2147890a4f39be824f4082c7ac83
Zobrazit plný text záznamu
2
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo
Autor: Le Xiong, Jun-Hua Nie, Xiao-Min Lin, Hai-Shan Ye, Jia Liu
Publikováno v: Nanotheranostics. 5:143-154
Background: Docetaxel and doxorubicin combination has been widely used in anaplastic thyroid cancer/ATC treatment but often results in serious adverse effects and drug resistance. Resveratrol effectively inhibits ATC cell proliferation in vitro witho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2bf685673f497804f38dc11371aad9f6
https://doi.org/10.7150/ntno.53844
Zobrazit plný text záznamu
3
Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs
Autor: Hai‐Shan Ye, Hong‐Fei Gao, Hong Li, Jun‐Hua Nie, Ting‐Ting Li, Meng‐Di Lu, Mo‐Li Wu, Jia Liu, Kun Wang
Publikováno v: Phytotherapy research : PTRREFERENCES. 36(8)
The lack of reliable drugs is a therapeutic challenge of advanced breast cancers (ABCs). Resveratrol (Res) exerts inhibitory effects on breast cancer cell lines and animal models, while its efficacy against individual breast cancer cases remains unkn
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b48b3d6ca56014b1e5d9e1328561e104
https://pubmed.ncbi.nlm.nih.gov/35649509
Zobrazit plný text záznamu
4
Efficacy of Resveratrol Against Advanced Breast Cancer-Derived Organoids: A comparison with that of Clinically Relevant Drugs
Autor: Hong Li, Jia Liu, Hai-Shan Ye, Meng-Di Lu, Ting-Ting Li, Mo-Li Wu, Kun Wang, Hong-Fei Gao, Jun-Hua Nie
Background: The lack of reliable drugs is a therapeutic challenge of advanced breast cancers (ABCs). Resveratrol (Res) exerts inhibitory effects on breast cancer cell lines and animal models, while its efficacy against individual breast cancer cases
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1afbe47bedb0047428f364e3e9f1bf8b
https://doi.org/10.21203/rs.3.rs-970702/v1
Zobrazit plný text záznamu
5
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
Autor: Hong Li, Jun-Hua Nie, Tao Yang, Bo-Le Du, Guo-Qing Zhong, Jin Xiao, Yu Zhang, Ting-Ting Li, Zhi Li, Hai-Shan Ye, Chi Zhang, Jia Liu, Jian-Li He, Wen-Han Huang
Publikováno v: Journal of Bone Oncology, Vol 30, Iss, Pp 100391-(2021)
Journal of Bone Oncology
Highlights • GPC3 mutation in primary osteosarcoma becomes abundant in its metastasis. • Mutant GPC3 is over-produced in metastatic spheroids with multidrug resistance. • Anti-GPC3 antibody effectively commits metastatic spheroids to apoptosis.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3d3dd6051b0684a8b2c3d5bd1813d14
http://www.sciencedirect.com/science/article/pii/S2212137421000464
Zobrazit plný text záznamu
6
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations
Autor: Meng-Di, Lu, Hong, Li, Jun-Hua, Nie, Sheng, Li, Hai-Shan, Ye, Ting-Ting, Li, Mo-Li, Wu, Jia, Liu
Publikováno v: International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14385
Anaplastic thyroid cancer is an extremely lethal malignancy without reliable treatment. BRAFV600E point mutation is common in ATCs, which leads to MAPK signaling activation and is regarded as a therapeutic target. Resveratrol inhibits ATC cell growth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac1699f745a88a448f13ccb1fd88a73
https://doi.org/10.3390/ijms232214385
Zobrazit plný text záznamu
7
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells
Autor: Le, Xiong, Xiao-Min, Lin, Jun-Hua, Nie, Hai-Shan, Ye, Jia, Liu
Publikováno v: Nanotheranostics
Background: Docetaxel and doxorubicin combination has been widely used in anaplastic thyroid cancer/ATC treatment but often results in serious adverse effects and drug resistance. Resveratrol effectively inhibits ATC cell proliferation in vitro witho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5b4dd2173da4dca83f29f36d7525d2a9
https://pubmed.ncbi.nlm.nih.gov/33457193
Zobrazit plný text záznamu
8
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
Autor: Le Xiong, Jun-Hua Nie, Xiao-Min Lin, Xiao-Xiao Shi, Hai-Shan Ye, Jin-Zi Du, Jia Liu
Publikováno v: International Journal of Molecular Sciences, Vol 22, Iss 10622, p 10622 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 19
Glioblastoma multiforme (GBM) is the most common lethal primary brain malignancy without reliable therapeutic drugs. IL-13Rα2 is frequently expressed in GBMs as a molecular marker. Resveratrol (Res) effectively inhibits GBM cell growth but has not b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676f4ae509e710b2171942f0bec4569b
https://doi.org/10.3390/ijms221910622
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje